# Efficacy and Safety of Diclofenac DDEA 2.32 % in Patient Suffering From Knee Osteoarthritis (OA)

> **NCT01967550** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 304 (actual)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **DRUG:** diclofenac diethylamine, DDEA 2.32% gel
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01967550
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 304 (ACTUAL)
- **Last updated:** 2015-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01967550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01967550, "Efficacy and Safety of Diclofenac DDEA 2.32 % in Patient Suffering From Knee Osteoarthritis (OA)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01967550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*